SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-16-737221
Filing Date
2016-10-13
Accepted
2016-10-13 08:35:33
Documents
5
Period of Report
2016-10-13
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d269879d8k.htm 8-K 19011
2 EX-99.1 d269879dex991.htm EX-99.1 145981
3 EX-99.2 d269879dex992.htm EX-99.2 228564
4 GRAPHIC g269879ex991pg04.jpg GRAPHIC 19030
5 GRAPHIC g269879ex991pg05.jpg GRAPHIC 54905
  Complete submission text file 0001193125-16-737221.txt   496764
Mailing Address 87 CAMBRIDGEPARK DRIVE CAMBRIDGE MA 02140
Business Address 87 CAMBRIDGEPARK DRIVE CAMBRIDGE MA 02140 617 621 8097
Dicerna Pharmaceuticals Inc (Filer) CIK: 0001399529 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36281 | Film No.: 161934106
SIC: 2834 Pharmaceutical Preparations